InstantGMP understands that biotech research companies are affected by the current COVID-19 crises and want to help. Today, we are announcing that we are offering COVID-19 Stimulus Grants to biotech companies involved in preclinical or clinical research.
CARY, N.C. (PRWEB) APRIL 07, 2020
We’re all affected by the current COVID-19 crisis and we understand that preclinical and clinical research may be slowing down. InstantGMP, Inc. wants to help by awarding COVID-19 Stimulus Grants that can help biotech companies keep up with their tasks in a virtual environment.
The grant includes a subscription to the InstantQMS™software, a full set of manufacturing and quality Standard Operating Procedures, an integration with a Learning Management System and 50 hours of Implementationsupport.
Here’s everything that is included in InstantQMS Quality Management System:
- Incident Log
- Complaint Log
- CAPA Log
- Audit Log
- Training Log
- Vendor Management
- Contract Management
- Document Management
- File Vault
- Full set of Standard Operating Procedures for a virtual biotech
- Full set of templates and forms for vendor management
- Integration with on-line learning management system
The software is an all-in-one quality and vendor management system that makes it easy to organize records and to keep traceability and training up to date. It comes complete with all the SOPs, templates and guided workflows that make it simple to get started and to stay in compliance with FDA and quality guidelines.
More information about the COVID-19 Stimulus Grants can be found at InstantGMP.com/covid-19-stimulus-grant.
COVID-19 Stimulus Grants for Biotech Research Companies
“We are committed to helping biotech companies get through this coronavirus pandemic and our software will help them more easily meet the FDA requirements for quality and vendor management,” said Dr. Richard Soltero, President of InstantGMP.
Share article on social media or email:
